Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Xanthine Derivatives that Selectively Inhibit Cyclic GMP Hydrolysis Potentiate Cardiac Contractile Effects of Isoproterenol but Not Those of Bethanecol

PHILLIP MUSHLIN, ROBERT C. BOERTH and JACK N. WELLS
Molecular Pharmacology July 1981, 20 (1) 190-194;
PHILLIP MUSHLIN
Department of Pharmacology, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROBERT C. BOERTH
Department of Pharmacology, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JACK N. WELLS
Department of Pharmacology, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

This study examines the abilities of xanthines to alter contractile and cyclic nucleotide responses to isoproterenol or bethanecol in left atria isolated from rabbits. Two of the xanthines studied (1-methyl-3-isobutyl-8-methoxymethylxanthine, and 1-methyl-3-isobutyl-8-t-butylxanthine) inhibited cyclic GMP hydrolysis more potently than cyclic AMP hydrolysis; another xanthine, theophylline, was equipotent at inhibiting the hydrolysis of the two cyclic nucleotides. All of the xanthines studied comparably potentiated contractile and cyclic AMP responses to isoproterenol (10-8 M), regardless of their potencies to inhibit cyclic GMP hydrolysis. These data indicate that cyclic GMP is not antiadrenergic. The selective inhibitor, 1-methyl-3-isobutyl-8-methoxymethylxanthine, at a concentration that elevated cyclic GMP content to a level that was 3-fold above that observed with bethanecol alone, failed to depress contractile force, alter cardiodepressant effects of bethanecol, or alter atrial cyclic GMP content in the presence of this choline ester. These results demonstrate that the inhibition of cyclic GMP phosphodiesterase neither produces negative inotropic effects nor enhances the cardiodepressant effects of cholinergic agents.

ACKNOWLEDGMENTS The authors wish to thank Drs. Joel G. Hardman and George L. Kramer for fruitful discussion and constructive criticism concerning this work.

  • Copyright © 1981 by The American Society for Pharmacology and Experimental Therapeutics

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 20, Issue 1
1 Jul 1981
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Xanthine Derivatives that Selectively Inhibit Cyclic GMP Hydrolysis Potentiate Cardiac Contractile Effects of Isoproterenol but Not Those of Bethanecol
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Xanthine Derivatives that Selectively Inhibit Cyclic GMP Hydrolysis Potentiate Cardiac Contractile Effects of Isoproterenol but Not Those of Bethanecol

PHILLIP MUSHLIN, ROBERT C. BOERTH and JACK N. WELLS
Molecular Pharmacology July 1, 1981, 20 (1) 190-194;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Xanthine Derivatives that Selectively Inhibit Cyclic GMP Hydrolysis Potentiate Cardiac Contractile Effects of Isoproterenol but Not Those of Bethanecol

PHILLIP MUSHLIN, ROBERT C. BOERTH and JACK N. WELLS
Molecular Pharmacology July 1, 1981, 20 (1) 190-194;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Michaelis Menten quantification of GPCR-G protein signalling
  • Human mAb 3F1 targeting the fuctional epitopes of Siglec-15
  • The regulation and mechanisms of ImKTX58 on KV1.3 channel
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics